PI
CTSO icon

PEAK6 Investments’s Cytosorbents Corp CTSO Stock Holding History

PEAK6 Investments’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,243
Closed -$26K – 3501
2019
Q3 		$26K Buy
+5,243
New +$30.5K ﹤0.01% 3504
2018
Q4 		– Sell
-25,475
Closed -$329K – 4129
2018
Q3 		$329K Buy
+25,475
New +$319K ﹤0.01% 2882

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

PEAK6 Investments's CTSO Position: Q4 2019 in Review

PEAK6 Investments sold out of Cytosorbents Corp (CTSO) in Q4 2019, closing a stake of 5,243 shares — an estimated $26K sold.

PEAK6 Investments first reported a position in CTSO in Q3 2018 and held it in 2 quarters. The position peaked at $329K in Q3 2018. 72 funds tracked by Wall St. Rank hold CTSO as of Q4 2019.

  • PEAK6 Investments reported no remaining Cytosorbents Corp position as of Q4 2019 after selling out during the quarter.
  • PEAK6 Investments sold 5,243 Cytosorbents Corp shares in Q4 2019, an estimated $26K.
  • PEAK6 Investments first reported a position in Cytosorbents Corp in Q3 2018 and held it in 2 quarters.
  • PEAK6 Investments's Cytosorbents Corp position peaked at $329K in Q3 2018.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2019.

Based on PEAK6 Investments's 13F filing for Q4 2019, filed 13 Feb 2020.